Gregory E. Jones
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 5
- Radiopharmaceutical Chemistry and Applications 3
- Oncology 5
- HER2/EGFR in Cancer Research 5
- Co-authors
- Yelena Kovtun (8 shared papers)Charlene A. Audette (6 shared papers)Ravi V. J. Chari (4 shared papers)Victor S. Goldmacher (4 shared papers)Wayne C. Widdison (3 shared papers)Sharon D. Wilhelm (3 shared papers)Rajeeva Singh (3 shared papers)Jan Pinkas (3 shared papers)
- Journals
- Radiation Research (2 papers)Molecular Pharmaceutics (2 papers)Molecular Cancer Therapeutics (2 papers)Blood Advances (1 paper)Cancer Research (1 paper)
- Partner nations
- United StatesAustraliaFrance
In The Last Decade
Gregory E. Jones
12 papers receiving 711 citations
Peers
Comparison fields: 5 of 44
- Oncology 548
- Radiology, Nuclear Medicine and Imaging 416
- Hematology 109
- Genetics 42
- Dermatology 33
Countries citing papers authored by Gregory E. Jones
This map shows the geographic impact of Gregory E. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory E. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory E. Jones more than expected).
Fields of papers citing papers by Gregory E. Jones
This network shows the impact of papers produced by Gregory E. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory E. Jones. The network helps show where Gregory E. Jones may publish in the future.
Co-authors
The 25 scholars most cited alongside Gregory E. Jones, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 228 | |
| 2 | 2011 | 182 | |
| 3 | 2018 | 150 | |
| 4 | 2018 | 62 | |
| 5 | 2015 | 47 | |
| 6 | 2016 | 33 | |
| 7 | 2015 | 23 | |
| 8 | 2006 | 12 | |
| 9 | 2015 | 7 | |
| 10 | 2016 | 6 | |
| 11 | 2010 | 3 | |
| 12 | Dosimetry for quantitative analysis of low dose ionizing radiation effects on humans in radiation therapy patients | 2004 | 2 |
| 13 | 2022 | 0 |
About Gregory E. Jones
Gregory E. Jones is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Radiation, Pulmonary and Respiratory Medicine and Immunology and Allergy, having authored 13 papers that have together received 755 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (5 papers), HER2/EGFR in Cancer Research (5 papers), Cancer therapeutics and mechanisms (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Advanced Radiotherapy Techniques (2 papers), Radiation Therapy and Dosimetry (2 papers), Acute Myeloid Leukemia Research (1 paper) and Nanoplatforms for cancer theranostics (1 paper). The work is most often cited by research in Oncology (548 citations), Radiology, Nuclear Medicine and Imaging (416 citations), Hematology (109 citations), Genetics (42 citations) and Dermatology (33 citations). Gregory E. Jones has collaborated with scholars based in United States, Australia and France. Frequent co-authors include Yelena Kovtun, Charlene A. Audette, Ravi V. J. Chari, Victor S. Goldmacher, Wayne C. Widdison, Sharon D. Wilhelm, Rajeeva Singh, Jan Pinkas, Olga Ab and John M. Lambert. Their work appears in journals such as Radiation Research, Molecular Pharmaceutics, Molecular Cancer Therapeutics, Blood Advances and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.